Arterial line insertion is a cornerstone of haemodynamic management across critical care, theatres and high-risk surgical pathways. As trusts seek to adhere to national guidance whilst also balancing workforce pressures, clinical competence and sustainability requirements, Vygon UK is strengthening its education offer.
Mark Chadwick, Business Development Manager for Haemodynamic Management at Vygon UK, explains: “Among the challenges facing NHS trusts is scrutiny around bloodstream infection rates, the quality of arterial access technique, and the reliability of the arterial signal delivered.
“That’s why we’re assisting our partners, as a trusted advisor, providing the education, evidence and support infrastructure needed to deliver safe, reliable arterial practice to a consistently high standard.”
Vygon’s education package for this care bundle – spanning pre-assessment, placement and removal of an arterial line – incorporates:
- Attending resident doctor inductions every February and August, covering arterial access technique, pack contents, and infection prevention evidence.
- Conducting bi-annual arterial line refresher training for nursing staff
- Providing access to Vygon’s dedicated learning platform, Campus Vygon, which hosts evidence-based free online sessions such as ‘Mastering Arterial Access’ and ‘Which arterial line for the best arterial signal quality?’
- Bespoke cost-modelling support, using locally audited catheter-related bloodstream infection (CRBSI) rates to build the financial case for procurement and finance leads.
Underpinning Vygon’s clinical education offer is its trusted Leadercath arterial product range.
The Leadercath catheter is unique to Vygon. It is the only arterial catheter range made from polyethylene (PE), which is recognised as the best material for arterial signal quality. Using the classic Seldinger guidewire technique, it provides superior arterial signal transmission – crucial for a patient’s haemodynamic management.
Mark adds: “Our priority is to tailor our products and support to ensure clinical procedures run smoothly and efficiently, and that treatments deliver faster and better recovery.
“We recognise the importance of value as well as outcomes, which is why we help trusts assess the financial impact of arterial access choices. By combining education, product quality and economic insight, Vygon can play a role in delivering UK-wide consistent, policy‑aligned arterial practice.”
For further information visit: https://vygon.co.uk/category/haemodynamic-management/arterial-access/
